Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder.
about
Interpretation of urine drug testing in pain patientsThe role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescriptionOpioids for chronic musculoskeletal pain: putting patient safety first.Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant resultsGuideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veteransA Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent painThe Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics.Days with pain and substance use disorders: is there an association?Managing pain in high-risk patients within a patient-centered medical home.Sex differences in the medical care of VA patients with chronic non-cancer pain.Care management practices for chronic pain in veterans prescribed high doses of opioid medications.Management of chronic pain with chronic opioid therapy in patients with substance use disordersManagement of pain with comorbid substance abuse.Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial.Behavioral Interventions Targeting Chronic Pain, Depression, and Substance Use Disorder in Primary Care.Factors Associated with Opioid Dose Increases: A Chart Review of Patients' First Year on Long-Term Opioids.Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use.The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality.Timeliness of Care Planning upon Initiation of Chronic Opioid Therapy for Chronic Pain.The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.Safe opioid prescribing: a long way to go.Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury.The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain.Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes.Clinician Referrals for Non-opioid Pain Care Following Discontinuation of Long-term Opioid Therapy Differ Based on Reasons for Discontinuation.
P2860
Q27011889-034C2D08-11E9-465E-BDF8-07ED30F4620FQ33657366-618CDFF6-18D6-455A-ADC2-8F2820A05FD5Q33677835-A0E9F384-4F25-423F-B229-5594C89FAADDQ34566925-1CE4C073-FF4F-42BF-AB60-0ACC75F79FE7Q34621800-9168E849-A8DB-4CF2-A035-69B5F26CB1B1Q35740890-B8A5C0F2-07A2-4457-BAD3-9FE896B54797Q36492446-25B812E6-324E-4C3B-B76B-D166C9CA8A44Q36808952-697955AC-7BDA-4C5C-B0FA-428C090680D4Q36862569-62FB55FD-E356-430A-B553-3FB0C7DCC84AQ36998502-57D219AB-5647-4353-A770-E64D6790A6D1Q37030946-DB3AA6A4-B703-4C5D-AC59-36B7CDC792CFQ37399703-54ABE3D4-8AC6-4E95-92C5-1062AFB06B77Q37494538-F00B5E02-AA10-48F6-8B25-61F2AFFBE574Q37523766-94DE5811-27AB-4CB7-8598-07201725305AQ38030486-A321BEDB-D050-4E09-926E-F69945689497Q38373836-AF5D1DC1-8066-4CC0-82DE-13B24315377EQ38826612-CCF5FED1-0141-4A2C-820F-08B99171C817Q38914400-668944FF-6DAE-489C-9CCD-B140D1E8C558Q39162177-17323EDB-C78C-4B42-BE1F-EBCECDB752CFQ40375901-0261036D-4AB0-4CB5-A230-B0139D49F778Q40394638-BF1BB869-E235-4025-B89E-8540EC54A4DBQ40483691-F1066EE4-DB8F-4606-8C15-03DBC3C175B6Q40948962-8F985583-ED49-422E-9B85-160BAF6D2645Q41499781-28853573-A067-4B4F-B078-1A2282FBC7DCQ42870106-65E4580B-6528-4A84-82B4-3CEDF7ED64A9Q44339237-6E0003FD-57E2-4585-9D7A-382276232A8EQ44349828-3EE57257-46A3-40BB-B1D7-5D95CE906723Q47100271-A4C735EC-D158-41B6-800A-A9CA03450A55Q47343047-724C2F6A-D64E-4F15-9E53-A8B85C0F287CQ52597302-3E5A5AEF-8FFE-4CC5-865F-9BD95D14DC6E
P2860
Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Adherence to clinical guidelin ...... s with substance use disorder.
@ast
Adherence to clinical guidelin ...... s with substance use disorder.
@en
type
label
Adherence to clinical guidelin ...... s with substance use disorder.
@ast
Adherence to clinical guidelin ...... s with substance use disorder.
@en
prefLabel
Adherence to clinical guidelin ...... s with substance use disorder.
@ast
Adherence to clinical guidelin ...... s with substance use disorder.
@en
P2860
P1476
Adherence to clinical guidelin ...... s with substance use disorder.
@en
P2093
Benjamin J Morasco
Jonathan P Duckart
P2860
P2888
P304
P356
10.1007/S11606-011-1734-5
P577
2011-05-12T00:00:00Z